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Abstract 
Chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) 
account for more than 200,000 American deaths each year, and are debilitating and costly 
conditions. Dyspnea, the subjective symptom of breathlessness, is the most common physical 
symptom among lung disease patients. These patients are also likely to experience depressive 
symptoms as well as cognitive impairment. Although the rate of chronic lung disease incidence 
is similar in men and women, relatively few studies have examined sex differences in 
psychological functioning of patients with pulmonary disease, and no prior study has explored 
sex differences in both COPD and IPF patients. Therefore, this study utilized archival data to 
investigate sex differences in the relationship between psychological and cognitive functioning 
among men (n = 21) and women (n = 10) diagnosed with COPD or IPF. At a routine clinic visit, 
participants completed self-report measures of distress and tests of cognitive and pulmonary 
function. Pearson correlations evaluated relationships among measures of cognitive function, 
psychological well-being, and pulmonary functioning. Analysis of variance evaluated sex 
differences on all outcome measures. Results indicated no sex difference in levels of depression 
or dyspnea; and depression was more highly correlated with dyspnea in men than in women. In a 
subgroup of participants matched on ventilatory impairment, women demonstrated better 
cognitive performance than men, but among both men and women, better quality of life was 
associated with enhanced cognitive functioning. The study was limited by small sample size, 
which reduced statistical power. However, results indicated that women with lung disease 
exhibited fewer symptoms of distress and better cognitive functioning than men. In addition, 
dyspnea appears to be more relevant for distress among men than among women. Thus, sex 
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differences may be important to consider in evaluating and treating symptoms exhibited by 
patients with chronic lung disease.  
Introduction 
Pulmonary disease is debilitating and costly to both patients and society. Chronic 
obstructive pulmonary disease (COPD), the third leading cause of death (Centers for Disease 
Control and Prevention [CDC], 2013), is a progressive lung disease that impairs breathing and 
most frequently results from long-term smoking and exposure to other lung irritants. In 2000, 
COPD accounted for 8 million outpatient and physician office visits, 1.5 million emergency 
room visits, and 726,000 inpatient hospitalizations in the United States (Mannino & Braman, 
2007; Mannino, Homa, Akinbami, Ford & Redd, 2002).  Furthermore, COPD remains the only 
cause of respiratory mortality with increasing incidence (Katsura, Yamada, Wakabayashi & 
Kida, 2007). Idiopathic pulmonary fibrosis (IPF), another type of lung disease, results in the 
thickening of lung tissue, the origin of which is unknown. Approximately two thirds of IPF 
patients die within five years of diagnosis, resulting in roughly 40,000 deaths each year (Raghu, 
Weycker, Edelsberg, Bradford, & Oster, 2006). Compounding the large economic and clinical 
burden of pulmonary disease, co-morbid symptoms of depression occur frequently in patients 
with COPD and IPF. Among these patients, there is a strong association between depression and 
dyspnea, the subjective symptom of breathlessness (De Vries et al., 2001; Di Marco et al., 2006). 
Historically, research in pulmonary disease has focused on men due to the demographics of 
smoking. Yet, Maninno et al. (2002) reported a five-fold increase between 1971 and 2000 in the 
mortality rate among women due to COPD with the consequence that more women die from 
COPD than men (Han et al., 2007). However, in spite of these serious implications for women 
with lung disease, research on gender differences in COPD and IPF, particularly in the 
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experience of distress and cognitive functioning, remains limited. 
Depression, a major public health problem, is highly prevalent, recurrent, and often 
chronic. Depression adversely impacts the progression and outcome of a variety of disabling 
conditions. 
 
The CDC (2013) estimates that one in 10 adults in the United States reports 
clinically significant levels of depression, with women reporting 1.5 to 3 times higher rates of 
depression than men (American Psychiatric Association [APA], 2013). Substantial health risks 
exist for both major depression and sub-threshold depressive symptoms. Untreated, depression 
can lead to decreased productivity, short-term disability, and increased work absence (CDC, 
2011).  A study of older men revealed an association between depressed mood at baseline and an 
increased risk for declines in muscle and grip strength over a three-year period, the latter of 
which predicts future functional limitations, declining overall health and increased disability 
(Rantanen et al., 2000; Rantanen, 2003). Furthermore, according to the World Health 
Organization (2012), depression is the primary contributor to disability worldwide. Additional 
research has linked depression with reduced effectiveness of rehabilitation in numerous 
conditions, including fractures, stroke, arthritis and chronic obstructive pulmonary disease (Katz, 
1996).  
In pulmonary disease, depression significantly impacts patients, healthcare and society. 
According to Stein et al. (2006), the comorbidity of lung disease and depression virtually doubles 
the likelihood of disability, work absence and healthcare utilization. In multiple studies of IPF, 
23% of patients endorse significant levels of depression (De Vries, Kessels, & Drent, 2001; 
Ryerson et al., 2011) compared to 6.6% in the adult population in the United States (Substance 
Abuse and Mental Health Services Administration [SAMHSA], 2011). A recent investigation of 
interstitial lung disease, a lung-disease category which encompasses IPF, revealed that clinically 
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significant levels of depression at baseline were the most significant predictors of depression 
severity at the six month follow-up.  Patients with clinically meaningful depression at initial 
evaluation experienced, at follow-up, a 34-fold increase in the odds of depression compared to 
those with no depression at baseline (Ryerson et al., 2012).  
Patients with COPD exhibit higher rates of depression than patients with other chronic 
conditions, including cancer, arthritis, coronary heart disease, diabetes and IPF (Cao et al., 2006; 
Ng et al., 2007). Among patients with COPD, the prevalence of depression ranges from 42% to 
71% (Maurer et al., 2008). In a sample of 18,588 participants over 50 years old, recruited from 
the 2004 United States’ Health and Retirement Survey, depressive symptoms were 2.7 times 
more frequent in respondents with COPD than in those without COPD (Schane, Woodruff, 
Covinsky, & Walter, 2008). Furthermore, COPD patients who endorse depressive symptoms 
have a higher likelihood of pulmonary disease exacerbations, increased duration of hospital 
admissions and decreased social and physical functioning (Cao et al., 2006; Ng et al., 2007). 
After controlling for both disease severity and additional risk factors, a link between depressive 
symptoms and risk of mortality prevails for those hospitalized with COPD (Ng et al., 2007). 
However, there is no correlation between depression and hospital readmissions (Ng et al., 2007). 
It has been suggested that perhaps the feelings of helplessness and despair adversely affect 
patients’ motivation and desire to seek medical help and, in doing so, reduce hospital 
readmission. As a result, lung disease patients may experience premature death (Ng et al., 2007).  
Depression comorbid with COPD may have additional adverse effects on self-perceived 
quality of life and overall health status (Ng et al., 2007). Considering depression and anxiety 
together as independent determinants of health-related quality of life in patients with lung 
disease, emotional state explains over half of the variation in health-related quality of life 
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(Martínez Francés, Tordera, Fuster, Martínez Moragón & Torrero, 2008). Despite the association 
between depression and lung disease, as well as the resulting costs in dollars, healthcare 
utilization, suffering and, ultimately, lost years of life, there is a relative lack of attention to 
significant depressive symptoms in chronic lung disease patients in both primary and specialized 
care, resulting in a lack of treatment and an intensification of distress (Ng et al., 2007).  
Additionally in COPD patients, dyspnea, the subjective awareness of shortness of breath, 
exacerbates the distress that accompanies lung disease. Although an association exists between 
depression and dyspnea, there is no correlation between dyspnea and pulmonary function in 
patients with lung disease (Grant, Heaton, McSweeny, Adams & Timms, 1982; Ryerson et al., 
2001). Recently, Ryerson et al. (2001) documented that depression and functional status 
contribute to the severity of dyspnea among COPD patients. Additionally, in IPF patients, 
dyspnea correlates with depression and overall quality of life (De Vries et al., 2001; Ryerson et 
al., 2011). Furthermore, Di Marco et al. (2006) suggest that depression may potentiate dyspnea, 
accentuating the impact of psychological distress in lung disease. Unfortunately, dyspnea is 
frequently refractory to available therapies and rehabilitation and, thus, likely compounds the 
distress of pulmonary disease (Collard & Pantilat, 2008). 
In patients with pulmonary disease, several studies have documented reduced cognitive 
functioning. Mildly to severely hypoxemic patients with COPD, those with an abnormally low 
level of blood oxygen, demonstrate cognitive difficulties in abstract reasoning, memory and 
coordination on simple motor tasks (Grant et al., 1982; Prigatano, Parsons, Levin, Wright & 
Hawryluk, 1983). Liesker et al. (2004) extended such findings to nonhypoxemic COPD patients. 
Compared to matched healthy controls, nonhypoxemic COPD patients experience significant 
cognitive dysfunction, especially on information-processing speed (Liesker et al., 2004). In other 
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studies, COPD patients demonstrate cognitive impairments in numerous domains including 
verbal learning, memory (Antonelli-Incalzi et al., 1997), fluid intelligence (Etnier & Berry, 
2001), semantic fluency (Kozora & Make, 2000), reaction time and attention (Klein, Gauggel, 
Sachs & Pohl, 2010). Many factors, including the severity of disease and physical and 
psychological functioning, may influence cognitive capabilities in patients with chronic lung 
disease (Klein et al., 2010; Orth et al., 2006). While it is evident that deficits in cognitive 
functioning create additional mental health concerns and impact the progression of lung disease, 
it is uncertain whether gender differences in distress relate to gender differences in cognitive 
functioning.  
Since women report more frequent depression and experience a higher mortality rate 
from COPD than men, research on sex differences in the experience of psychological 
accompaniments of chronic lung disease is warranted. Recently, however, Di Marco et al. (2006) 
observed gender differences in disease symptoms and severity in a sample of 202 COPD 
patients. Compared to men, women endorsed higher levels of anxiety and depression as well as 
higher self-reported levels of dyspnea for the same level of ventilatory impairment. Furthermore, 
the correlation between dyspnea and depression was greater in women than in men. According to 
Han et al. (2010), dyspnea diminishes physical quality-of-life for men while it exacerbates 
emotional distress for women, suggesting that lung disease may have differing effects on the 
psychological functioning of men and women. A study of COPD patients by Carrasco-Garrido et 
al. (2009) reveals that women experience more comorbidity and poorer quality of life.  After 
adjusting for lung function and smoking burden, Martínez et al. (2008) found that women 
diagnosed with COPD reported greater dyspnea, depression and lower health status compared to 
men. Whether sex differences reflect comorbidities, such as depression and anxiety, or 
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physiologic differences, is unknown. In an international survey study, women were more likely 
to report severe dyspnea than men, despite documenting similar degrees of cough (Watson et al., 
2004). Additionally, the sex difference in symptom reporting may reflect a response bias, 
specifically the tendency on the part of men to underreport depressive and psychological 
symptoms (Sigmon et al., 2005).  However, further investigation of potential sex differences in 
lung disease patients will provide a more complete understanding of depression and dyspnea 
associated with pulmonary disease.  
In addition to depression and dyspnea, the intensity of symptoms and health-related 
quality of life may differ by sex among patients with lung disease. In a study by de Torres et al. 
(2005), women reported greater dyspnea despite being significantly younger in age and engaging 
in less smoking behavior than men. In an additional clinical study, women scored lower than 
men with a similar degree of physiologic impairment in all domains of the St. George’s 
Respiratory Questionnaire (SGRQ), an instrument designed to assess impact of obstructive 
airway disease on overall health, daily life, and perceived well-being (de Torres et al., 2006).  In 
other words, despite comparable levels of physiologic impairment, women experienced more 
severe dyspnea and worse health status than men. Dales, Mehdizadeh, Aaron, Vandemheen and 
Clinch (2006) replicated the findings of de Torres et al. (2005), documenting that women with 
lung disease were more likely than men to report respiratory symptoms. The authors 
hypothesized that the gender difference may be a result of a difference in the severity or 
expression of disease.  
Despite studies of patients with pulmonary disease documenting greater psychological 
distress among women than men, research on gender differences in lung disease, particularly in 
the experience of distress and cognitive function, remains limited. The lack of pulmonary 
SEX, DISTRESS, AND COGNITIVE FUNCTION IN LUNG DISEASE   9 
 
 
research involving gender differences is problematic, since death rates from COPD tripled for 
women between 1980 and 2000. Additionally, in 2000, for the first time, more women than men 
died of COPD, while population-based mortality rates remained higher among men (Mannino et 
al., 2002). The increasing prevalence of COPD and mortality among women may result in part 
from increased tobacco use, yet studies suggest that women, given the same level of tobacco 
exposure, may actually have a greater risk of developing smoking-induced impairment in 
pulmonary functioning, may experience more severe dyspnea, and may have poorer overall 
health (Han et al., 2007). Interestingly, research has also indicated that nonsmokers who develop 
COPD are more likely to be female than male (Birring et al., 2002). Regardless of the cause or 
causes, the increases in prevalence and death among women with COPD underscore the need for 
both clinical and public health interventions in the management and treatment of chronic lung 
disease. 
Additionally, numerous studies have found evidence of gender bias in the diagnosis of 
COPD by primary care physicians. Chapman, Tashkin and Pye (2001) presented 200 primary 
care physicians in North America with two hypothetical cases of dyspnea and cough in smokers, 
differing only by sex. When asked for a diagnosis, physicians diagnosed COPD significantly 
more frequently for the male case than for the female. More recently, a similar study conducted 
by Miravitlles et al. (2006), confirmed these findings in a sample of physicians in Spain. 
However, displaying to the physicians results of spirometry, indications of atypical volume 
and/or flow of air, eliminated the gender bias in their diagnoses. Unfortunately, other research 
demonstrates that primary care physicians under-utilize spirometry (Kesten and Chapman, 1993). 
In addition, women receive fewer referrals for spirometry than men (Franks, Clancy, & 
Naumburg, 1995). Thus, women may be less likely than men to receive a diagnosis of COPD, 
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and consequently, the disease in women is more likely to remain untreated. Therefore, further 
research into sex differences in the psychological and cognitive functioning of chronic lung 
disease patients is needed.  
 Limited literature has investigated sex differences in psychological and cognitive 
functioning among patients with chronic lung disease. The few existing studies document 
significant sex differences. Therefore, this study will evaluate sex differences in symptoms of 
depression and dyspnea among patients with COPD and IPF, as well as the degree to which 
depression and dyspnea relate to cognitive function, in order to confirm findings from previous 
studies and extend the study of sex differences to the cognitive domain.  
The present research assessed four hypotheses. Of these hypotheses, two replicate 
previous studies. Thus, it was hypothesized that (1) women will report more symptoms of both 
depression and dyspnea than men and (2) measures of depression and dyspnea will be more 
highly correlated among women than among men. Additionally, the remaining two hypotheses 
extended previous research to additional domains. Therefore, it was hypothesized that (3) there 
will be an inverse correlation between cognitive performance and levels of distress. Additionally, 
(4) when matched with men with the same level of ventilatory impairment, women will exhibit 
greater cognitive dysfunction than men.   
 Methods  
Participants 
This study utilized archival data collected between 2007 and 2008. The larger 
longitudinal study assessed depression, stress, cognitive function, and pro-inflammatory cytokine 
production among 31 men and women diagnosed with COPD or IPF (Emery, 2008).  
Recruitment occurred during patients’ routine medical appointments in the outpatient pulmonary 
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clinics at The Ohio State University Medical Center. Participants with COPD met diagnostic 
criteria for COPD set forth by the American Thoracic Society (ATS) and the European 
Respiratory Society (ERS; Celli et al., 2004). 
 Participants in the study exhibited symptoms of sputum (mucus) production, cough 
and/or dyspnea on exertion. Potential subjects were excluded if they had expected survival of 
less than six months (as a result of lung disease or other medical conditions). Additionally, the 
study deemed female participants ineligible if they were pregnant or became pregnant during the 
study.  
Procedures 
At a routine clinic visit, participants completed informed consent, self-report measures of 
depression, anxiety, sleep, quality of life, and dyspnea, and tests of cognitive function were 
administered. The visit also incorporated standard pulmonary function tests. 
Psychological/Behavioral Measures 
 Participants completed the following self-report measures.  
Beck Anxiety Inventory (BAI). The Beck Anxiety Inventory measures both cognitive 
and physiological symptoms of anxiety through 21 self-report items. The measure has good 
internal consistency (Cronbach’s α = .92) and good test-retest reliability (r =.71; Beck et al., 
1998). Additionally, the BAI appears more precise in discriminating anxiety from depression 
than other self-report anxiety scores (Beck et al., 1988). 
 Center for Epidemiological Studies Depression Scale (CESD). The CESD, a 20-item 
measure of depressive symptomatology, has excellent construct validity and acceptable test-
retest reliability (Basco, Krebaum & Rush, 1997; Radloff, 1977). Additionally, the discriminant 
validity appears acceptable as it differentiates between depressed and non-depressed participants
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in both community and clinical samples (Basco et al., 1997). Population norms for depressive 
symptomatology afford cutoffs for varying levels of depression (Basco et al., 1997).   
University of California at San Diego Shortness of Breath Questionnaire (UCSD). 
The UCSD assesses the occurrence of shortness of breath (dyspnea) during 21 activities of daily 
living. Respondents rate the severity of dyspnea on a 6-point scale for each of 24 items (Eakin, 
Resnikoff, Prewitt, Ries, & Kaplan, 1998). Summary scores range from 0 to 120, with higher 
scores indicating greater perception of dyspnea. The UCSD has excellent internal consistency 
(Cronbach’s α = 0.96) and good validity, significantly correlating with a variety of measures 
including FEV1 (r = -0.45, p < 0.001), the Quality of Well-Being Scale (r = -0.37,  p < 0.01), 
CESD (r = 0.42,  p < 0.001), 6 Minute Walk distance (r = - 0.67,  p < 0.001), perceived 
breathlessness (r = 0.47,  p < 0.001), and muscle fatigue (r = 0.28,  p < 0.001; Eakin et al., 1998).  
 St. George’s Respiratory Questionnaire (SGRQ). The SGRQ assesses the impact of 
obstructive airway disease on patients’ overall health, daily life, and perceived well-being (Jones, 
Quirk, Baveystock & Littlejohns, 1992). The disease-specific measure contains 50 items that 
yield three domain scores: Symptom (frequency and severity); Activity (activities that cause or 
are limited by breathlessness); and Impact (social functioning and psychological disturbances 
resulting from airway disease) as well as an overall score. Studies indicate the SGRQ to be a 
reliable and valid measure for use among patients with chronic lung disease (Jones et al., 1992; 
Tzanakis et al., 2005).  
RAND 36-Item Short Form Health Survey (SF-36). The SF-36, a multi-purpose health 
survey, contains 36 questions. The survey assesses eight domains of health and well-being as 
well as provides physical and mental health summary measures and a health utility index. The 
present research focused exclusively on the physical and mental health summary measures. The 
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physical component score (PCS) more heavily reflects the four health concepts of physical 
functioning, bodily pain, role limitations due to physical health problems, and general health 
perceptions. The mental health component score (MCS) more heavily assesses the domains of 
social functioning, energy/fatigue, role limitations due to personal or emotional problems and, 
general mental health. The SF-36 serves as a generic measure since it does not target a given age, 
disease or treatment group.   
Pittsburgh Sleep Quality Index. The Pittsburgh Sleep Quality Index (PSQI) is a self-
rated questionnaire of sleep quality as well as sleep disturbances (Buysse, Reynolds, Monk, 
Berman, & Kupfer, 1989). The PSQI is comprised of 7 sub-scales including subjective sleep 
quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of 
sleeping medications, and daytime dysfunction. These sub-scores can be summed to generate a 
global score. In differentiating between good and poor sleepers, the measure provides good 
diagnostic sensitivity and specificity. Research suggests that sleep quality influences both 
endocrine and immune function (Redwine, Hauger, Gillin, & Irwin, 2000; Vgontzas et al., 1999). 
Furthermore, in lung disease patients, an association exists between sleep quality and depression, 
anxiety, and dyspnea (Hill, Geist, Goldstein, & Lacasse, 2008). 
Cognitive/Neuropsychological Measures 
During the visit, participants completed a short battery of cognitive measures to examine 
areas of executive functioning that may be impaired in patients with chronic lung disease and 
which may be correlated with depression or dyspnea. Each cognitive measure is robust to 
practice effects, with alternate forms utilized at repeated assessments. Additionally, clinicians 
frequently employ such measures in evaluating patients’ overall brain function and frontal lobe 
(executive) function in particular.  
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Controlled Oral Word Association Test (COWAT). The COWAT, part of the 
Halstead-Reitan battery, indicates a subject’s organized verbal processing ability. The measure is 
comprised of two tasks, the letter task and the category task. For the letter task, respondents are 
given one minute to name as many words as possible that begin with a specific letter, excluding 
proper nouns and suffix variations. The test consists of three letters of increasing difficulty. 
Summing the number of acceptable words generated across the three levels yields an overall 
score, with a higher score indicating better performance. For the category task, respondents are 
given one minute to generate as many words as possible that fit within a specific category (e.g. 
animal). Summing the number of items generated that fit within the category yields an overall 
score for the measure, with a higher score indicating better performance.  The COWAT has 
excellent test-retest reliability (r = .88; Spreen & Strauss, 1991).  
Digit Symbol. The Digit Symbol subscale from the Wechsler Adult Intelligence Scale - 
Revised (WAIS-R), measures psychomotor speed, sequencing ability and implicit memory. 
Utilizing a coding key, participants write a series of symbols that correspond with specific 
printed digits as rapidly as possible. The test lasts for 90 seconds and the number of correct 
symbols drawn in this time period determines the score. The measure has high test-retest 
reliability (r =.88; Wechsler, 1981). 
The Trail Making Test. The Trail Making Test assesses mental flexibility, attention, 
speed of processing and perceptual motor speed. The test is comprised of two independently 
timed trials. In Part A, the participant must connect 25 randomly dispersed circled numbers in 
numerical order, providing a widely accepted measure of sustained attention. Part B is similar to 
Part A, except that the numbers alternate with letters. Again, the participant connects the 
representations sequentially (i.e., 1 to A to 2 to B, etc.) as quickly as possible. Completion of this 
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task generates a well-respected assessment of executive function. Overall, the Trail Making Test 
has good test-retest reliability with coefficients ranging from .70 to .90 (Spreen & Strauss, 
1991).  
The Stroop Interference Test. The Stroop Interference Test assesses a respondent’s 
ability to shift perceptual sets, attend selectively, and inhibit responses (Stroop, 1935).  
Additionally, the measure demonstrates adequate reliability (r = .73 – .86; Reitan, 1958). This 
study utilized Golden’s (Golden, 1978) version of the Stroop Interference Task with three timed 
45-second trials that utilize word, color, and interference lists. In the first trial, participants read 
aloud a list of color names, printed in black ink, as fast as possible. The second trial uses a list of 
color names printed in different color inks. Subjects read the listed words again, as quickly as 
possible. The last trial utilizes the same list of color words but, rather than reading the word, the 
participant must identify the color of ink of the color word, again as quickly as possible. This 
trial specifically requires the inhibition of semantic content, forcing participants to ignore the 
printed word, while focusing instead on the color of ink.   
Pulmonary Function Testing   
 
 Standard pulmonary function testing equipment (Sensormedics 2450) indicated the flow 
rate of air as well as the volume of expired air following a maximum inspiration. Specifically, 
measurements included the forced vital capacity (FVC) and forced expiratory volume at 1 
second (FEV1), measured in liters/second. Patients inhaled completely, and then exhaled into a 
mouthpiece using as much force as possible. FEV1 indicates the volume of air expelled from the 
patient’s lungs during the first second of expiration. FVC reflects the total amount of air the 
patient expired. Research has demonstrated that FEV1 is one of the most sensitive measures of 
the severity of COPD. The FEV1/FVC ratio, commonly used in diagnosis of COPD, provides an 
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indicator of the obstruction in pulmonary disease (Fletcher & Peto, 1997; Fletcher, Peto, Tinker, 
& Speizer, 1976). An FEV1/FVC ratio of less than .70 is reflective of significant impairment in 
lung function. For each patient, comparing the FEV1, FVC and the FEV1/FVC ratio to published 
norms (according to age, sex and height) characterized the individual’s severity of lung disease.  
Six Minute Walk with Oximetery 
 
Participants completed the six-minute walk test (6MWT) on a level, 30-meter linear 
track, in accordance with ATS guidelines. Following the provided instructions, participants 
walked as fast and as far as possible over the 6-minute interval, stopping to rest as needed. The 
data collector carried oxygen for those requiring it in order to complete the test. The 6MWT is a 
relatively simple and reliable assessment of functional exercise capacity (Stevens et al., 1999), 
utilized frequently in studies of lung disease as well as in clinical practice (Sciurbam et al., 
2003). When compared to other maximum exercise tests, the 6MWT strongly correlates with 
severity of symptoms and quality of life (Stevens et al., 1999).   
Data Analysis  
The SAS (V9.03) statistical program for Windows was used for all data analyses. To 
evaluate demographic differences chi-square tests and one-way ANOVAs were conducted. To 
assess potential sex differences, one-way ANOVAs were conducted for all psychological, 
cognitive and pulmonary variables. Pearson product correlations evaluated relationships among 
measures of psychological wellbeing, cognitive functioning and pulmonary functioning.  
Results 
Preliminary Analyses 
Preliminary analyses were conducted to evaluate diagnostic differences between the 
COPD and IPF groups on demographic characteristics, psychological well-being and cognitive 
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functioning. Additional analyses assessed sex differences on demographic characteristics, 
cognitive functioning, and pulmonary functioning.  
Diagnostic Group Differences. As shown in Table 1, the COPD and IPF groups were 
generally similar with regard to demographic characteristics, although the COPD group was 
significantly younger, F(1, 29) = 9.00, p = .006.  
As shown in Table 2, the COPD group exhibited poorer pulmonary functioning than the 
IPF group as reflected by FEV1 and FEV1/FVC. Additionally, the COPD group experienced 
significantly greater psychological distress than the IPF group. Specifically, the COPD group 
reported greater depression, greater dyspnea, greater anxiety, and poorer quality of life. The 
diagnostic groups did not differ on any measure of cognitive functioning. 
Sex Differences. As indicated in Table 3, men and women did not differ in age, 
education, weight, or ethnicity.  
To assess sex differences, independent sample ANOVAs were utilized for all measures of 
pulmonary functioning. As shown in Table 3, FVC and FEV1 were significantly greater in men 
than women. Men walked significantly farther than women during the six-minute walk test, in 
line with expectations, given their typically larger body sizes and higher pulmonary function 
values.  
For each neuropsychological test, ANOVA assessed sex differences. Despite the absence 
of sex differences in psychological distress, women performed better than men at baseline on 
both the Digit Symbol Test (F(1, 29) = 5.88, p = .022) and the Word t-score on the Stroop 
Interference Task (F(1, 29) = 5.91, p = .022), as shown in Table 4. There were no other sex 
differences in cognitive performance.  
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Hypothesis One 
ANOVA was used to evaluate sex differences on all psychological measures. As shown 
in Table 4, men and women reported similar levels of distress, contrary to expectation.  
The first hypothesis, that women will report more depression and greater dyspnea than 
men, was not supported; depression, F(1, 28) = 0.41, p = .528; dyspnea, F(1, 28) = 1.44, p = 
0.240. 
Hypothesis Two 
A Pearson correlation between depression and dyspnea was used to evaluate the 
relationship of depression and dyspnea among women and among men. Contrary to predictions, 
depression and dyspnea were more highly correlated in men (r(19) = .67, p < .001) than in 
women (r(7) = .49, p = .160).  
Hypothesis Three 
For the third hypothesis, Pearson correlations assessed the degree of association between 
each cognitive measure and measures of depression, dyspnea, anxiety, sleep, and quality of life. 
Correlational analyses were conducted for the full sample as well as within the sample of men 
and within the sample of women. 
As shown in Table 5, in the full sample, quality of life, as assessed by the SGRQ, was 
moderately correlated with the Stroop Word Raw Score, indicating that decreased quality of life 
was associated with poorer cognitive performance, r(28) = -.42, p = .022. Similarly, there was a 
trend for the physical component score (PCS) on the SF-36 to be positively correlated with 
Stroop Word Raw Score, such that poorer quality of life was associated with greater cognitive 
dysfunction, r(28) =.36, p = .057. These effects appear to be generated by the men in the sample. 
Among men, Pearson correlations revealed a relationship between decreased quality of life 
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(SGRQ) and Stroop Word Raw Score, r(19) = -.48, p = .026, and between physical quality of life 
(PCS) and Stroop Word Raw score, r(17) = .45, p = .054. In both correlations, worse quality of 
life was associated with poorer cognitive performance.  
Additional relationships between quality of life and cognitive performance, not apparent 
in the full sample, were also observed among men. There was an association of decreased quality 
of life (SGRQ) with Trails A, r(19) = -.42, p = .061, and with the Digit Symbol subtest, r(17) = 
.43, p = .068, with both correlations reflecting a trend of  greater cognitive impairment. 
Among women, as shown in Table 5, increased dyspnea, as indicated by the UCSD 
measure, was associated with poorer Stroop Color Raw performance, r(7) = -.68, p = .042. 
Mental quality of life (MCS) was associated with Stroop Word t-scores such that worse quality 
of life correlated with decreased cognitive functioning, r(7) = .70, p = .034. There was a trend for 
increased depression, indicated by a higher CESD score, to be associated with poorer Stroop 
Word t-score performance, r(7) = -.62, p = .076.  
Exploratory Analyses. To further expand on the third hypothesis, exploratory analyses 
were conducted with Pearson correlations to assess the relationship between each of the 
cognitive measures and the three measures of pulmonary functioning (FEV1, FVC, and 
FEV1/FVC) as well as the measure of exercise capacity (6MWT).  Correlational analyses were 
conducted for the full sample as well as within the sample of men and within the sample of 
women. 
 Pulmonary functioning as assessed by FVC in the full sample was inversely correlated 
with Trails B such that decreased pulmonary function was associated with slower performance 
on Trails B, r(27) = -.37, p = .043.  
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Among men, lower functional capacity, assessed by the 6MWT, was associated with 
lower Stroop Color Raw scores, indicating that those who were less able to walk also had poorer 
cognitive functioning, r(16) = .47, p =.050.  
Among women, lower pulmonary function, as assessed by FEV1 and FVC, was 
correlated with poorer performance on the Stroop Color Raw Score, r(7) = .70, p = .036 and r(7) 
= .64, p = .064, respectively. Additionally, there was a significant relationship between lower 
FVC and lower Stroop Color Word Raw Score, r(7) = .81, p = .008. Each of these correlations 
suggests that within women, lower pulmonary function was associated with poorer cognitive 
performance.  
Hypothesis Four  
To assess the fourth hypothesis, 20 individuals were matched, 10 women and 10 men, on 
level of pulmonary impairment using FEV1/FVC. For each cognitive measure, ANOVA was 
used to determine whether the scores of men significantly differed from those of women. Only 
the Digit Span subtest revealed a significant sex difference, F(1,18) = 4.61, p = .046. Contrary to 
the predictions, women performed significantly better than men on this measure.   
Exploratory Analyses. Exploratory analyses were conducted to further examine this 
hypothesis. Using the same subset of 20 individuals, analyses determined whether men and 
women with the same level of ventilatory impairment differed in levels of psychological distress 
or other indicators of pulmonary functioning. There were no sex differences on any of the 
psychological measures, but men consistently indicated more distress than women across all 
psychological measures. On indicators of pulmonary functioning other than FEV1/FVC, men and 
women only differed on the distance walked during the six minute walk test, F(1,18) = 6.44, p = 
.021. Men walked further than women, which is consistent with both the full sample and with 
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data from other samples (both healthy and chronically ill) indicating that men have higher levels 
of functional capacity than women.  
Discussion 
 
This study is one of few to investigate sex differences in psychological and cognitive 
functioning among patients with chronic lung disease.  
Contrary to our first hypothesis, women did not report more symptoms of depression and 
dyspnea than men. Post hoc power analyses were conducted to assess whether the non-
significant results were due to a lack of statistical power. The power analysis for the difference in 
mean depression scores between men and women yielded a power of .10 for an effect size of .27 
while the difference in mean dyspnea scores between men and women yielded a power of .22 for 
an effect size of .49, both of which are considerably lower than the recommended power level of 
.80 (Cohen, 1992). Although the effect size for the difference in dyspnea is moderate to large, the 
power was limited likely due to the small sample of women (n = 10). This may explain not only 
the lack of significant findings but also the deviations of our results from those in the literature.  
Depression and dyspnea were correlated both in men and in women. However, in contrast 
to earlier findings by Di Marco et al. (2006), the association was only significant in men, not in 
women. Although the correlation in women, r(7) = .49, did not reach significance, the magnitude 
of the correlation was moderate to large suggesting a substantial relationship between the 
variables. The absence of a significant relationship between depression and dyspnea in women 
may also be the result of an inadequate sample size and thus limited statistical power.  
Despite the absence of gender differences in reported psychological distress, women 
performed better than men on the Digit Symbol task, a reliable measure of psychomotor speed. 
This effect was also observed in the analyses of the subset of male-female pairs matched on 
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pulmonary functioning. These results deviated from the hypothesis that women would exhibit 
greater cognitive dysfunction, associated with increased depression and dyspnea, than men with 
the same level of ventilatory impairment. However, within the matched subset, men indicated 
more psychological distress than women on every self-report measure, although the differences 
were not statistically significant. This elevated distress and increased endorsement of depression 
and anxiety among men is consistent with the slower psychomotor speed.  
The finding that women reported fewer symptoms of distress than men with the same 
level of ventilatory impairment contrasts with findings of Di Marco et al. (2006). This deviation 
from the results of Di Marco et al. (2006) may be attributed to diagnostic differences within the 
samples studied. Whereas the findings of Di Marco et al. are based on a sample of COPD 
patients, the sample for this study included men and women with IPF as well as COPD. 
Although there was not a significant difference in the rates of diagnoses among men and women 
in our study, it is possible that our results differed from past results due to the fact that half of the 
sample was comprised of IPF patients.  Additionally, preliminary analyses showed that the IPF 
patients in this study were significantly older and exhibited greater pulmonary functioning and 
less psychological distress than the COPD group.   
Our preliminary analyses also indicated that women performed significantly better than 
men on both the Digit Symbol subtest and Word T-score on the Stroop, contrary to expectations. 
It is possible that the women in this study were exceptionally resilient and therefore performed 
better than expected, or that women with lung disease exhibit better cognitive functioning than 
men.  
In evaluating the third hypothesis, we found that better quality of life was correlated with 
better cognitive performance in men and in women. This finding is consistent with data from 
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exercise intervention studies in patients with COPD (Emery et al., 1998; Kozora, Tran, & Make, 
2002). Additionally in women, there was a significant relationship between greater dyspnea and 
poorer cognitive performance (Stroop Color Raw score), in line with predictions. These findings, 
in women and in men, lend support for our hypothesis that in COPD and IPF populations, 
cognitive performance and level of psychological distress are correlated.  
Exploratory analyses, expanding upon the third hypothesis, indicated that in the full 
sample, poorer pulmonary functioning (FVC) was associated with poorer cognitive performance 
(Trails B). Likewise, in women, lower pulmonary functioning (FEV and FVC) was significantly 
linked to lower cognitive performance (multiple scores on the Stroop). Similarly, in men, lower 
exercise capacity (6MWT) was significantly correlated with poorer cognitive functioning (Stroop 
Color Raw score). These results reflect a relationship between lower functional and exercise 
capacity and decreased cognitive ability.  
Limitations 
The results of this study are limited by numerous factors. As previously mentioned, the 
small sample of women may have limited the statistical power of many of the analyses 
conducted. Additionally, this was a clinic-based study and therefore the patients included may 
not be representative of the entire population of COPD and IPF patients. Combining patients 
with differing pulmonary diagnoses may have obscured effects that would otherwise have been 
observed.  Furthermore, the generalizability of our results is further hindered by the lack of 
ethnic diversity of our sample, as only one of the 31 participants identified with an ethnicity 
other than “Caucasian.” 
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Summary 
 In regards to sex differences in psychological distress and cognitive functioning, our 
predictions were only partially supported. The lack of sex differences on a number of measures 
may be attributable to our small sample size and the resulting limited statistical power. However, 
it may also be that, in the sample studied, the degree of impairment was such that it negated 
typically observed sex differences, such as those in depression and dyspnea. The women in this 
sample may have been exceptionally resilient and thus performed better than expected. If so, this 
may explain the sex differences that contrasted with past studies. However, it may also be that 
women with chronic lung disease indeed do exhibit fewer symptoms of distress and better 
cognitive functioning than men. Overall, dyspnea appears to be a more relevant indicator of 
distress in men than in women. Thus, sex differences may be important to consider in evaluating 
and treating symptoms exhibited by patients with chronic lung disease. Given the results of this 
study, future research examining sex differences in patients with pulmonary disease utilizing a 
larger sample size is warranted.  
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Table 1 
Characteristics of the Diagnostic Groups  
 
 
 
 
COPD 
(n = 16) 
  
IPF 
(n = 15) 
 
   
Variable M SD  M SD p 
Age 58.69  11.47  69.33  7.81 .006 
Education 13.22  2.99  14.37  2.61 .266 
Weight 179.94  51.02  200.07  42.73 .245 
 n %  n %  
Gender 
 Female 
   Male 
 
5 
11 
 
31.25 
68.75 
  
5 
10 
 
33.33 
66.67 
.901 
 
Ethnicity 
   Caucasian 
   Black 
 
15 
1 
 
93.75 
3.23 
 
 
 
15 
0 
 
100 
0 
.325 
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Table 2 
Characteristics of the Diagnostic Groups  
 
 
 
 
COPD 
 
  
IPF 
 
 
     
Variable n M SD  n M SD p 
Physiological          
   FEV1
 16 1.40  .97  15 2.22 .62 .009 
   FVC 16 3.00 .97  15 2.78  .86 .512 
   FEV1/FVC 16 .43 .18  15 .81 .06   < .001 
   6MWT 16 332.50 111.84  15 337.33 74.56 .889 
         
Psychological  
   
       
 
 
   CESD 16 15.72 10.22  15 7.83 5.72 .016 
   UCSD 16 47.40 18.61  15 27.26 15.23 .003 
   BAI 16 12.61 7.89  15 4.80 5.33 .004 
   PSQI 16 7.69 3.66  15 6.20 3.75 .273 
   SGRQ         
      Overall 16 50.42 15.27  15 36.53 17.00 .022 
      Symptom 16 60.89 22.24  15 37.72 16.68 .005 
      Activity 16 69.19 20.35  15 55.35 20.35 .062 
      Impact 16 36.16 15.90  15 25.19 18.18 .061 
   SF-36         
      PCS 14 34.37 8.38  15 42.57 8.72 .021 
      MCS 14 48.43 12.73  15 57.55 4.38 .014 
         
Cognitive 
   Trail Making 
  
  
 
 
 
 
 
  
 
 
 
 
 
 
      Trails A 16 41.68 15.32  15 37.16 11.90 .369 
      Trails B 16 115.82 55.56  14 108.4 49.27 .690 
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  Digit Span 16 41.75 7.33  15 41.93 8.18 .948 
  COWAT         
     Letter 16 27.88 7.19  15 27.53 6.32 .890 
     Category 16 23.38 4.77  15 23.53 4.29 .924 
  Stroop         
    Word Raw 16 79.19 12.28  15 85.07 10.37 .162 
    Word T  16 35.35 8.23  15 38.67 7.25 .231 
    Color Raw 15 59.33 8.26  13 61.15 10.52 .613 
    Color T  15 38.00  6.90  13 40.23  9.00 .465 
    Color Word Raw 15 30.87  8.09  13 31.54  6.96 .817 
    Color Word T  15 44.27  9.44  13 46.62  6.84 .464 
Note. FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; 6MWT = six 
minute walk test; CESD = Center for Epidemiologic Studies Depression Scale; UCSD = 
University of California at San Diego Shortness of Breath Questionnaire; BAI = Beck Anxiety 
Inventory; SGRQ = St. George’s Respiratory Questionnaire; PCS = Physical Component 
Summary; MCS = Mental Component Summary; COWAT = Controlled Oral Word Association 
Test 
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Table 3 
Characteristics of Sex Groups  
 
 
 
 
Men 
(n = 21) 
  
Women 
(n = 10) 
 
   
Variable M SD  M        SD           P 
Age 63.48  12.37  64.60  8.41 .797 
Education 13.90  3.07  13.00  2.37 .716 
Weight 200.29  49.15  167.40  36.67 .071 
 n %  n %  
Ethnicity 
   Caucasian 
   Black 
 
1 
1 
 
93.75 
3.23 
 
 
 
15 
0 
 
100 
0 
 
       
 M  SD  M SD p 
Pulmonary Function       
FEV1 2.07  .90  1.24  .66 .015 
FVC 3.22  .86  2.19  .56 .002 
FEV1/FVC .63  .20  .59  .29 .674 
6MWT 360.38  100.45  281.20  48.70 .026 
Note. FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; 6MWT = six 
minute walk test 
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Table 4  
Psychological Well-Being and Cognitive Functioning  
 
 
 
 
Men 
 
  
Women 
 
 
     
Measure n M SD  n M SD p 
 
Psychological 
        
CESD 21 12.52  10.21  10 10.62 6.65 .528 
BAI 21 8.75  8.64  10 9.00  5.89 .993 
UCSD 21 34.71  20.50  10 44.30  17.15 .240 
SF-36         
    PCS 21 39.45  10.20  10 37.01  7.85 .613 
    MCS 19 51.42  10.77  10 54.62  8.98 .214 
SGRQ         
    Overall 21 43.98  20.10  10 43.11  10.30 .926 
    Symptom 21 51.48  24.19  10 45.91  19.87 .304 
    Activity 21 59.60  23.01  10 68.58  15.19 .246 
    Impact 21 32.25  20.06  10 27.69  11.36 .612 
PSQI 21 6.76  3.53  9 7.33  4.50 .711 
Cognitive         
Trail Making         
     Trails A 21 38.22  13.91  10 42.17  13.69 .465 
     Trails B 20 115.41  52.12  10 105.75  53.83 .640 
Digit Symbol 21 39.71  6.00  10 46.30  8.99 .022 
COWAT         
   Letter 21 26.24  7.36  10 30.80  3.52 .074 
   Category  21 23.48  4.55  10 23.40  4.55 .966 
Stroop         
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  Word Raw 21 79.24  10.46  10 87.90  12.19 .050 
  Word T  21 34.71  6.69  10 41.50  8.41 .022 
  Color Raw 18 58.11  8.15  10 63.90  10.33 .114 
  Color T  18 37.22  7.30  10 42.30  8.17 .103 
  Color Word Raw 18 30.44  7.30  10 32.50  9.23 .494 
  Color Word T  18 44.50  8.40  10 46.90  8.23 .472 
Note. CESD = Center for Epidemiologic Studies Depression Scale; UCSD = University of 
California at San Diego Shortness of Breath Questionnaire; BAI = Beck Anxiety Inventory; 
SGRQ = St. George’s Respiratory Questionnaire; PCS = Physical Component Summary; MCS = 
Mental Component Summary; COWAT = Controlled Oral Word Association Test 
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Table 5 
Intercorrelations of Psychological and Cognitive Variables 
 
 BAI CESD SGRQ UCSD PSQI MCS PCS 
Trails A 
 
-.19 
-.38 
.51 
 
-.16 
-.33 
.50 
-.27 
-.42 
.41 
-.10 
-.31 
.46 
-.12 
-.20 
.02 
-.07 
.10 
-.58 
-.05 
.17 
-.53 
Trails B 
 
-.05 
-.07 
.03 
 
.08 
.00 
.31 
.21 
.20 
.21 
.11 
.12 
.41 
-.13 
-.02 
-.49 
.12 
.33 
-.41 
 
-.23 
-.29 
-.09 
Word Raw -.28 
-.23 
-.51 
-.30 
-.22 
-.49 
 
-.42* 
-.48* 
-.32 
 
-.31 
-.36 
-.51 
 
.07 
.03 
.08 
 
.20 
-.03 
.51 
.36 
.45 
.38 
 
Word T -.19 
-.12 
-.45 
-.24 
-.08 
-.62 
-.19 
-.22 
-.19 
-.10 
-.12 
-.37 
.19 
.16 
.20 
.30 
.03 
.70 
.19 
.25 
.24 
Color Raw .05 
.23 
-.39 
-.01 
.21 
-.39 
-.05 
.08 
-.40 
-.08 
.07 
-.68* 
.29 
.45 
.10 
.06 
-.27 
.36 
-.01 
-.06 
.22 
Color T .07 
.24 
-.38 
-.02 
.20 
-.51 
.03 
.16 
-.34 
.02 
.16 
-.61 
.31 
.42 
.18 
.17 
-.11 
.51 
-.19 
-.17 
.13 
Color 
Word Raw 
.14 
.33 
-.19 
.08 
.26 
-.24 
.02 
.22 
-.48 
.04 
.32 
-.48 
.11 
.21 
-.02 
-.13 
-.18 
-.17 
-.19 
-.21 
-.16 
Color 
Word T 
.12 
.25 
-.20 
.04 
.20 
-.40 
.11 
.26 
-.42 
.16 
.35 
-.38 
.12 
.15 
.08 
.06 
.05 
-.02 
-.29 
-.29 
-.27 
COWAT        
  Letter .11 
.12 
.12 
 
.10 
.18 
-.06 
.21 
.25 
-.02 
.21 
.20 
-.15 
.46* 
.50* 
.47 
-.10 
-.26 
.08 
-.30 
-.31 
-.19 
  Category  .13 
.06 
.41 
.03 
-.01 
.23 
 
.01 
-.10 
.62 
.05 
-.09 
.41 
.02 
-.24 
.59 
-.12 
-.20 
.03 
.00 
.15 
-.46 
Digit 
Symbol 
.07 
-.05 
-.16 
-.23 
-.11 
-.46 
-.12 
-.10 
-.27 
-.14 
-.23 
-.35 
.21 
-.01 
.45 
.25 
.03 
.41 
.14 
.43 
-.16 
 
Note. Bold text indicates full sample (n = 31). Normal text indicates men (n = 21). Italicized text 
indicates women (n = 9). BAI = Beck Anxiety Inventory; SGRQ = St. George’s Respiratory 
Questionnaire; PCS = Physical Component Summary; MCS = Mental Component Summary; 
COWAT = Controlled Oral Word Association Test. * p < .05. 
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Beck Anxiety Inventory (BAI) 
 
Below is a list of common symptoms of anxiety.  Please carefully read each item in the list.  Indicate how 
much you have been bothered by each symptom during the PAST WEEK, INCLUDING TODAY, by 
placing an X in the corresponding space in the column next to each symptom.   
 
 
                    NOT               MILDLY               MODERATELY      SEVERELY 
                       AT   It did not                   It was very unpleasant           I could barely 
                    ALL        bother me too much.             but I could stand it.              stand it. 
 
1. Numbness or tingling.    ______    ______        ______                            ______ 
2. Feeling hot.     ______    ______        ______                            ______ 
3. Wobbliness in legs.     ______    ______        ______                            ______ 
4. Unable to relax.     ______    ______        ______                            ______ 
5. Fear of the worst happening.   ______    ______        ______                            ______ 
6. Dizzy or lightheaded.    ______    ______        ______                            ______ 
7. Heart pounding or racing.    ______    ______        ______                            ______ 
8. Unsteady.     ______    ______        ______                            ______ 
9. Terrified.      ______    ______        ______                           ______ 
10. Nervous.      ______    ______        ______                           ______ 
11. Feelings of choking.     ______    ______        ______                           ______ 
12. Hands trembling.   ______    ______        ______                          ______ 
13. Shaky.    ______    ______        ______                          ______ 
14. Fear of losing control.  ______    ______        ______                          ______ 
15. Difficulty breathing.   ______    ______        ______                          ______ 
16. Fear of dying.   ______    ______        ______                          ______ 
17. Scared.    ______    ______        ______                          ______ 
18. Indigestion or  
       discomfort in abdomen.  ______    ______        ______                          ______ 
 
19. Faint.    ______    ______        ______                          ______ 
20. Face flushed.   ______    ______        ______                          ______ 
21. Sweating (not due to heat).  ______    ______        ______                          ______ 
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Center for Epidemiological Studies Depression Scale (CESD) 
 
Circle the number for each statement which best describes how often you felt or 
behaved this way – DURING THE PAST WEEK. 
 
 
 
DURING THE PAST WEEK: 
Rarely or none 
of the time 
(less than 1 
day) 
 
Some or a little 
of the time (1-2 
days) 
 
Occasionally or 
a moderate 
amount of time 
(3-4 days) 
 
Most of or 
all of the 
time (5-7 
days) 
 
1. I was bothered by things that usually 
don’t bother me. 
 
0 
 
1 
 
2 
 
3 
2. I did not feel like eating; my appetite 
was poor. 
 
0 
 
1 
 
2 
 
3 
3. I felt that I could not shake off the 
blues even with help from my family or 
friends. 
 
0 
 
1 
 
2 
 
3 
4. I felt that I was just as good as other 
people. 
 
0 
 
1 
 
2 
 
3 
5. I had trouble keeping my mind on what 
I was doing. 
 
0 
 
1 
 
2 
 
3 
6. I felt depressed 0 1 2 3 
7. I felt that everything I did was an 
effort. 
 
0 
 
1 
 
2 
 
3 
8. I felt hopeful about the future. 0 1 2 3 
9. I thought my life has been a failure. 0 1 2 3 
10. I felt fearful. 0 1 2 3 
11. My sleep was restless. 0 1 2 3 
12. I was happy. 0 1 2 3 
13. I talked less than usual 0 1 2 3 
14. I felt lonely. 0 1 2 3 
15. People were unfriendly. 0 1 2 3 
16. I enjoyed life. 0 1 2 3 
17. I had crying spells. 0 1 2 3 
18. I felt sad. 0 1 2 3 
19. I felt that people disliked me. 0 1 2 3 
20. I could not get “going.” 0 1 2 3 
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UCSD Shortness-of-Breath Questionnaire 
 
Instructions:  For each activity listed below, please rate your breathlessness on a scale between 
zero and five, where 0 is not at all breathless and 5 is maximally breathless or too breathless to do 
the activity.  If the activity is one which you do not perform, please give your best estimate of 
breathlessness. Your response should be for an “average” day during the past week. Please 
respond to all items.  Read the two examples below then begin the questionnaire. 
 
Example 1: 
How short of breath do you get while: 
 1.  Brushing teeth… 
 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
Harry has felt moderately short of breath during the past week while brushing his teeth 
and so circles a three for this activity. 
 
Example 2: 
How short of breath do you get while: 
 2.  Mowing the lawn: 
  
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
Anne has never mowed the lawn before but estimates that she would have been too 
breathless to do this activity during the past week.  She circles a five for this activity. 
             
 
BEGIN QUESTIONNAIRE 
 
When I do, or if I were to do, the following tasks, I would rate my breathlessness as: 
 
1.  At rest… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
2.  Walking on a level at your own pace: 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
3.  Walking on a level with others your age: 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
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When I do, or if I were to do, the following tasks, I would rate my breathlessness as: 
 
4.  Walking up a hill… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
5.  Walking up stairs… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
6.  While eating… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
7.  Standing up from a chair… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
8.  Brushing teeth… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
9.  Shaving and/or brushing hair… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
10.  Showering, bathing… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
11.  Dressing… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
12.  Picking up and straightening… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
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13.  Doing dishes…  
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
When I do, or if I were to do, the following tasks, I would rate my breathlessness as: 
 
14.  Sweeping/vacuuming… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
15.  Making bed… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
16.  Shopping… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
17.  Doing laundry… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
18.  Washing car… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
19.  Mowing lawn… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
20.  Watering lawn… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
21.  Sexual activities… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
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How much do these limit you in your daily life? 
 
 
22.  Shortness of breath… 
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
How much do these limit you in your daily life? 
 
 
23.  Fear of “hurting myself” by overexerting…  
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
 
 
24.  Fear of shortness of breath…  
 0-----------------1-----------------2-----------------3-----------------4-----------------5 
     Not at all                Severely    Unable to do 
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THE 36-ITEM SHORT-FORM HEALTH SURVEY (SF-36) 
 
INSTRUCTIONS: This survey asks you for your views about your health. This 
information will help keep track of how you feel and how well you are able to do 
your usual activities. 
 
Answer every question by marking the answer as indicated. If you are unsure about 
how  
to answer a question, please give the best answer that you can. 
 
 
1.  In general, would you say your health is: 
(Circle one) 
 
 Excellent………………………………………………………………1 
 
 Very Good…………………………………………………………… 2 
 
 
 Good……………………………………………………………………3 
 
 
 Fair………………………………………………………………………4 
 
 
 Poor……………………………………………………………………...5 
 
 
2.  Compares to one year ago, how would you rate your health in general now? 
(Circle one) 
 
  Much better now than one year ago…………………………………… 1 
 
  Somewhat better now than one year ago…………………………… 2 
 
  About the same as one year ago………………………………………… 3  
 
  Somewhat worse now than one year ago……………………………4 
 
  Much worse now than one year ago…………………………………….5 
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3. The following items are about activities you might do during a typical day. 
Does your health now limit you in these activities? If so, how much? 
 
ACTIVITIES     YES  YES  NO, Not 
      Limited   Limited  Limited 
        A Lot  A Little    At All 
 
a. Vigorous activities, such as running, lifting 
     heavy objects, participating in strenuous                  1       2        3 
     sports 
 
 
b. Moderate activities, such as moving a table, 
     pushing a vacuum cleaner, bowling, or     1       2        3 
     playing golf 
 
c. Lifting or carrying groceries      1       2        3 
 
d. Climbing several flights of stairs     1       2        3 
 
e. Climbing one flight of stairs      1       2        3 
 
f. Bending, kneeling, or stooping      1       2        3 
 
g. Walking more than a mile      1       2        3 
 
h. Walking several blocks      1       2        3 
 
i.  Walking one block       1       2         3 
 
j. Bathing or dressing yourself      1       2        3 
 
 
4.  During the past 4 weeks have you had any of the following health problems 
with your work or other regular activities as a result of your physical health? 
 
 YES                          NO 
 
a.   Cut down on the amount of time that you spent on 
work or other activities                 1              2 
 
b.   Accomplished less than you would like                             1              2 
 
c.   Were limited in the kind or work or other activities             1              2 
 
d.   Had difficulty performing the work or other 
activities (for example, it took extra effort)                             1              2 
 
 
SEX, DISTRESS, AND COGNITIVE FUNCTION IN LUNG DISEASE   48 
 
 
5.  During the past 4 weeks, have you had any of the following problems with your work or 
other daily as a result of any emotional problems (such as feeling depressed or anxious) ? 
 
 YES                            NO                          
                                                   
a.   Cut down on the amount of time you spent on work or 
activities                                  1            2 
 
b. Accomplished less than you would like               1            2 
 
c. Didn’t do work or other activities as carefully as usual                              1            2 
 
 
6.  During the past 4 weeks, to what extent has your physical health or emotional  
problems interfered with your normal social activities with family, friends, 
neighbors, or groups? 
 
  (Circle one) 
 
  Not at all………………………………………………………….……1 
 
  Slightly…………………………………………………………………2 
 
  Moderately………………………………………………………..…3 
 
  Quite a bit……………………………………………………………4 
 
  Extremely……………………………………………………………5 
 
 
7.  How much bodily pain have you had in the past 4 weeks? 
   
  None………………………………………………………………1 
 
  Very mild……………………………………………………… 2 
 
  Mild………………………………………………………………. 3 
 
  Moderate…………………………………………………………4 
 
  Severe…………………………………………………………….5 
 
  Very severe………………………………………………………6 
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8.  During the past 4 weeks, how much did pain interefere with your normal work  
(including both work outside the home and housework)? 
 
                                                  (Circle one) 
 
  Not at all…………………………………………………………....1 
 
  A little bit…………………………………………………………...2 
 
  Moderately………………………………………………………….3 
 
  Quite a bit…………………………………………………………...4 
 
  Extremely…………………………………………………………...5 
 
9.  These questions are about how you feel and how things have been with you 
during the past 4 weeks. For each question, please give one answer that comes  
closest to the way that you have been feeling. How much of the time in the past 4 
weeks: 
(Circle one number on each line)   
                              All          Most          A Good      Some     Little       None 
                of the      of the        bit of  of the     of the      of the  
                 Time       Time        the Time     Time      Time      Time 
 
a.   Did you feel full of pep?                 1         2                 3        4               5               6 
 
b.   Have you been a very 
      Nervous person?                    1         2                    3        4           5               6 
 
c.   Have you felt so down 
      In the dumps that 
     Nothing could cheer 
     You up?                     1         2                 3        4           5               6 
 
d.   Have you felt calm and 
      Peaceful?                     1         2                 3        4           5               6 
 
e.   Did you have a lot of 
      Energy?                     1         2                 3        4           5               6 
 
f.   Have you felt 
      Downhearted and blue?                  1         2                    3        4           5               6 
 
g.   Did you feel worn out?       1         2                 3        4           5               6 
 
h.   Have you been a happy person?     1         2   3        4           5               6 
 
i.   Did you feel tired?                        1         2                 3        4           5               6 
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10. During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with 
friends, relatives, etc.)? 
                                                                                                  (Circle one) 
 
   All of the time……………………………………………………1 
    
   Most of the time……………………………………………….2 
 
   Some of the time………………………………………………3 
 
   A little bit of the time…………………………………………4 
 
   None of the time……………………………………………….5 
 
 
11. How TRUE or FALSE is each of the following statements for you? 
 
(circle one number on each line) 
 
            Definitely         Mostly     Don’t          Mostly     Definitely 
                 True           True     Know           False         False 
 
a.  I seem to get sick a 
     Little easier than 
     Other people  1            2       3            4            5 
 
b.  I am as healthy as 
     Anybody I know  1            2       3            4            5 
 
c.  I expect my health to  
    Get worse   1  2       3  4  5 
 
d. My health is 
    Excellent   1  2       3  4  5 
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St. George’s Respiratory Questionnaire 
PART 1 
 
Questions about how much chest problem you have had over the past 4 weeks. 
 
Please checkmark () one box for each question: 
 
 Most 
days  
a week 
Several 
days  
a week 
A few 
days  
a month 
Only with 
chest 
infections 
Not  
at  
all 
1. Over the past 4 weeks, I have coughed:      
 
2. Over the past 4 weeks, I have brought up  
phlegm (sputum):      
 
3. Over the past 4 weeks, I have had shortness  
of breath:       
 
4. Over the past 4 weeks, I have had attacks  
of wheezing:       
 
5. During the past 4 weeks, how many severe or very  
unpleasant attacks of chest problem have you had? 
Please checkmark () one box only: 
                                                                   more than 3 attacks  
 3 attacks  
                                                                                 2 attacks  
 1 attack  
 no attacks  
 
6. How long did the worst attack of chest problem last: 
(Go to question 7 if you had no severe attacks) 
Please checkmark () one box only: 
                                                                         a week or more  
 3 days or more  
 1 or 2 days  
 Less than a day  
 
7. Over the past 4 weeks, in an average week, how many good days 
(with little chest problem) have you had: 
Please checkmark () one box only: 
                                                                          No good days  
 1 or 2 good days  
 3 or 4 good days  
 Nearly every day was good  
 Every day was good  
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8. If you have a wheeze, is it worse in the morning: 
Please checkmark () one box only: 
                                                                                         No  
 Yes  
 
St. George’s Respiratory Questionnaire 
PART 2 
Section 1 
 
How would you describe your chest condition? 
                                                                                                         Please checkmark () one box only: 
                                                          The most important problem I have  
 Causes me quite a lot of problems  
 Causes me a few problems  
 Causes me no problem  
 
If you have ever had paid employment. 
                                                                                                         Please checkmark () one box only: 
                                 My chest problem made me stop work altogether  
 My chest problem interferes with my work or made me change my work  
 My chest problem does not affect my work  
 
Section 2 
 
Questions about what activities usually make you feel breathless these days. 
 
For each item, please checkmark () 
the box as it applies to you these days: 
                                                                            True False 
                   Sitting or lying still   
    Getting washed or dressed   
       Walking around at home   
 Walking outside on the level   
 Climbing up a flight of stairs   
                          Climbing hills   
        Playing sports or games   
Section 3 
 
Some more questions about your cough and breathlessness these days. 
For each item, please checkmark () the 
box as it applies to you these days: 
                                                                         True False 
 My cough hurts                        
 My cough makes me tired   
 I am breathless when I talk   
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 I am breathless when I bend over   
 My cough or breathing disturbs my sleep   
  I get exhausted easily   
 
Section 4 
 
Questions about other effects that your chest problem may have on you these days. 
 
For each item, please checkmark 
() the box as it applies to you these 
days: 
                                                                                                        True False 
 My cough or breathing is embarrassing in public          
                  My chest problem is a nuisance to my family, friends or neighbours   
 I get afraid or panic when I cannot get my breath   
 I feel that I am not in control of my chest problem   
              I do not expect my chest to get any better   
                                         I have become frail or an invalid because of my chest   
                                       Exercise is not safe for me   
                Everything seems too much of an effort   
 
Section 5 
 
Questions about your medication. If you are taking no medication go straight to Section 6. 
 
For each item, please checkmark () the 
box as it applies to you these days: 
                                                                                                                           True False 
            My medication does not help me very much   
    I get embarrassed using my medication in public   
 I have unpleasant side effects from my medication   
                My medication interferes with my life a lot   
Section 6 
 
These are questions about how your activities might be affected by your breathing. 
 
For each item, please checkmark () 
the box as it applies to you because 
of your breathing: 
                                                                                                                 True False 
                     I take a long time to get washed or dressed   
         I cannot take a bath or shower, or I take a long time   
            I walk slower than other people, or I stop for rests   
                       Jobs such as housework take a long time, or I have to stop for rests   
 If I walk up one flight of stairs, I have to go slowly or stop   
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                If I hurry or walk fast, I have to stop or slow down   
 
  My breathing makes it difficult to do things such as climbing up hills, carrying  
  things up stairs, light gardening such as weeding, dancing, playing bowls or golf     
 
My breathing makes it difficult to do things such as carrying heavy loads,digging 
the garden or shovelling snow, jogging or walking at 8 kilometres per hour, playing 
 tennis or swimming                                                                                                               
 
My breathing makes it difficult to do things such as very heavy manual work,  
running, cycling, swimming fast or playing competitive sports                 
 
 
Section 7 
 
We would like to know how your chest problem usually affects your daily life. 
 
For each item, please checkmark () 
the box as it applies to you because of 
your chest problem: 
                                                                                                                            True False 
                             I cannot play sports or games   
 I cannot go out for entertainment or recreation   
 I cannot go out of the house to do the groceries   
                          I cannot do housework   
         I cannot move far from my bed or chair   
 
Here is a list of other activities that your chest problem may prevent you doing (you do not have 
to checkmark these, they are just to remind you of ways in which your breathlessness may affect 
you): 
 
Going for walks or walking the dog 
Doing things at home or in the garden 
Sexual intercourse 
Going out to church or place of entertainment 
Going out in bad weather or into smoky rooms 
Visiting family or friends or playing with children 
 
 
Please write in any other important activities that your chest problem may stop you doing: 
 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   
 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   
SEX, DISTRESS, AND COGNITIVE FUNCTION IN LUNG DISEASE   55 
 
 
Now, would you checkmark the box (one only) which you think best describes how your chest affects you: 
 
                              It does not stop me doing anything I would like to do  
 It stops me doing one or two things I would like to do  
 It stops me doing most of the things I would like to do  
 It stops me doing everything I would like to do  
 
Thank you for filling in this questionnaire. Before you finish, would you check to see that you have 
answered all the questions. 
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PITTSBURGH SLEEP QUALITY INDEX 
 
INSTRUCTIONS: 
The following questions relate to your usual sleep habits during the past month only. Your 
answers should indicate the most accurate reply for the majority of days and nights in the 
past month. Please answer all questions. 
 
 
 
1. During the past month, what time have you usually gone to bed at night?  
 
BED TIME ___________ 
 
2. During the past month, how long (in minutes) has it usually taken you to fall asleep each 
night?  
 
NUMBER OF MINUTES ___________ 
 
3. During the past month, what time have you usually gotten up in the morning?  
 
GETTING UP TIME ___________ 
 
4. During the past month, how many hours of actual sleep did you get at night? (This 
may be different than the number of hours you spent in bed.)  
 
HOURS OF SLEEP PER NIGHT ___________ 
 
 
For each of the remaining questions, check the one best response.  Please answer all 
questions. 
 
5. During the past month, how often have you had trouble sleeping because you . . .  
 
a) Cannot get to sleep within 30 minutes  
 
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
 
b) Wake up in the middle of the night or early morning  
 
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
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c) Have to get up to use the bathroom  
 
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
 
d)  Cannot breathe comfortably  
 
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
 
e)  Cough or snore loudly  
 
 Not during the Less than Once or twice Three or more 
 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
f) Feel too cold    
 Not during the Less than Once or twice Three or more 
 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
g) Feel too hot    
 Not during the Less than Once or twice Three or more 
 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
h) 
Had bad 
dreams    
 Not during the Less than Once or twice Three or more 
 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
i) Have pain    
 Not during the Less than Once or twice Three or more 
 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
 
j)      Other reasons, please describe ____________________________________________  
 
 ___________________________________________________________________ 
 
 
How often during the past month have you had trouble sleeping because of this? 
 
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
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6.  During the past month, how would you rate your sleep quality overall?  
 
Very good   ___________ 
 
Fairly good  ___________ 
 
Fairly bad   ___________ 
 
Very bad ___________ 
 
7.  During the past month, how often have you taken medicine to help you sleep 
(prescribed or "over the counter")?  
 
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
 
 
8.  During the past month, how often have you had trouble staying awake while 
driving, eating meals, or engaging in social activity?  
 
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
 
 
9.  During the past month, how much of a problem has it been for you to keep up 
enough enthusiasm to get things done?  
 
No problem at all __________ 
 
Only a very slight problem __________ 
 
Somewhat of a problem __________ 
 
A very big problem __________ 
 
10. Do you have a bed partner or room mate? 
 
No bed partner or room mate __________ 
 
Partner/room mate in other room __________ 
 
Partner in same room, but not same bed __________ 
 
Partner in same bed __________ 
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11. If you have a room mate or bed partner, ask him/her how often in the past month you 
have had . . . 
 
a) Loud snoring    
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
 
b) Long pauses between breaths while asleep  
 
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
 
c)  Legs twitching or jerking while you sleep  
 
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
 
d)  Episodes of disorientation or confusion during sleep  
 
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
 
e)  Other restlessness while you sleep, please describe _________________ 
________________________________________________________________ 
________________________________________________________________ 
 
Not during the Less than Once or twice Three or more 
past 
month_____ 
once a 
week_____ a week_____ 
times a 
week_____ 
 
